Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy

导出原文传递

翻译打印收藏纠错

作者： Sha, Chulin ^[1] ; Barrans, Sharon ^[2] ; Cucco, Francesco ^[3] ; Bentley, Michael A. ^[4] ; Care, Matthew A. ^[5] ; Cummin, Thomas ^[6] ; Kennedy, Hannah ; Thompson, Joe S. ; Uddin, Rahman ; Worrillow, Lisa ; Chalkley, Rebecca ; van Hoppe, Moniek ; Ahmed, Sophia ; Maishman, Tom ; Caddy, Josh ; Schuh, Anna ; Mamot, Christoph ; Burton, Catherine ; Tooze, Reuben ; Davies, Andrew ; Du, Ming-Qing ; Johnson, Peter W. M. ; Westhead, David R.

作者单位： Univ Cambridge, Cambridge, England ^[1] Cantonal Hosp Aarau, Aarau Swiss Grp Clin Canc Res, Aarau, Switzerland ^[2] Univ Leeds, Leeds, W Yorkshire, England ^[3] St James Univ Hosp, Leeds, W Yorkshire, England ^[4] Univ Southampton, Canc Res UK Ctr, Southampton, Hants, England ^[5] Univ Oxford, Oxford, England ^[6]

发布时间 2019-04-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Journal of Clinical Oncology

2019年37卷3期

202-212页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy

Journal of Clinical Oncology

相似文献

Journal of Clinical Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy

Journal of Clinical Oncology

相似文献

Journal of Clinical Oncology

相关期刊

检索历史清除